1201 W la Veta Ave, Orange, CA, 92868 · (714) 997-3000
Beds
386
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$1.37B
FY 2025
Net income
$203.0M
Patient care margin -6.4%
Discharges
14,309
Occupancy 68.7%
Clinicians
10
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1.37B | $1.46B | -6.4% | $203.0M | 14,309 | - | 0.1% | 19.0% |
Medicare clinicians who list this hospital, by specialty
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5183 Level 3 Vascular Procedures | - | - | - | $2,405.01 |
| APC 5113 Level 3 Musculoskeletal Procedures | - | - | - | $2,373.24 |
| APC 5163 Level 3 ENT Procedures | - |
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $1.15B | $1.31B | -13.9% | $120.2M | 12,253 | - | 0.1% | 19.5% |
| 2023 | $1.31B | $1.30B | 0.7% | $238.7M | 13,043 | - | 0.1% | 21.1% |
| 2022 | $895.4M | $1.04B | -16.4% | $50.7M | 11,852 | - | 0.1% | 23.1% |
| 2021 | $699.4M | $923.4M | -32.0% | -$12.6M | 10,643 | - | 0.2% | 20.6% |
| 2020 | $732.1M | $912.4M | -24.6% | $36.0M | 13,030 | - | 0.1% | 22.4% |
| - |
| - |
| $1,105.91 |
| APC 5182 Level 2 Vascular Procedures | - | - | - | $1,204.32 |
| APC 5362 Level 2 Laparoscopy and Related Services | - | - | - | $8,164.45 |
| APC 5465 Level 5 Neurostimulator and Related Procedures | - | - | - | $26,719.00 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 18 | $819K |
| Ultragenyx Pharmaceutical Inc. RARE | 20 | $307K |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $128K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $107K |
| Jazz Pharmaceuticals Inc. JAZZ | 10 | $105K |
| Masimo Corporation MASI | 70 | $95K |
| Smith+Nephew, Inc. SNN | 2 | $88K |
| Biogen, Inc. BIIB | 1 | $58K |
| Ucb Sa UCB.BR | 4 | $57K |
| Abbott Laboratories ABT | 2 | $53K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Children's Hospital of Orange County is a nonprofit children's hospital in Orange, CA with 386 beds, part of CHOC Childrens.
Children's Hospital of Orange County in Orange, CA has 386 beds (fiscal year 2025 cost report); 192 beds are certified for Medicare. It discharged 14,309 inpatients that year, with 68.7% of its beds in use on average.
In fiscal year 2025 (ending 2025-06-30), Children's Hospital of Orange County reported net patient revenue of $1.37B and operating expenses of $1.46B, a margin on patient care of -6.4%. After other income and expenses its net income was $203.0M (12.2% of revenue), so it made a profit that year.
Children's Hospital of Orange County is part of CHOC Childrens, a health system with 2 hospitals based in San Diego, CA. It is a nonprofit hospital.
Children's Hospital of Orange County has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
No, Children's Hospital of Orange County does not list emergency services.
10 Medicare clinicians list Children's Hospital of Orange County as a hospital they work at, most often in Pediatric Medicine, Emergency Medicine, Neurology.
In 2025, companies reported $2.4M in payments to Children's Hospital of Orange County as a teaching hospital ($265K general and $2.1M for research) from 53 companies.